Phase II study of dovitinib in first line metastatic or (nonresectable primary) adrenocortical carcinoma (ACC): SOGUG study 2011-03.
Jesús García-Donas
Honoraria - Novartis
Research Funding - Novartis
Susana Hernando Polo
No relevant relationships to disclose
Marta Guix
No relevant relationships to disclose
Miguel Angel Climent Duran
No relevant relationships to disclose
Maria Jose Mendez Vidal
No relevant relationships to disclose
Paula Jiménez
No relevant relationships to disclose
Luis Leon Mateos
No relevant relationships to disclose
Juan Francisco Rodriguez-Moreno
No relevant relationships to disclose
Fernando Moreno
No relevant relationships to disclose
Eduardo Segura
Employment or Leadership Position - Novartis
Ignacio Duran
No relevant relationships to disclose
Sonia Maciá
No relevant relationships to disclose
Jose Angel Arranz Arija
No relevant relationships to disclose
Sergio Vazquez-Estevez
No relevant relationships to disclose
Francisco Javier Perez
No relevant relationships to disclose
Nuria Lainez
No relevant relationships to disclose
Daniel E. Castellano
No relevant relationships to disclose